| PERIOD ENDING | 30-Sep-09 | 30-Sep-08 | | Total Revenue | 649,100 | 678,100 | | Cost of Revenue | 374,700 | 397,600 | | | Gross Profit | 274,400 | 280,500 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 119,400 | 130,900 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 155,000 | 149,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,900 | 5,900 | | Earnings Before Interest And Taxes | 162,900 | 155,500 | | Interest Expense | 2,100 | 2,200 | | Income Before Tax | 160,800 | 153,300 | | Income Tax Expense | 58,500 | 60,100 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 102,300 | 93,200 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 102,300 | 93,200 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $102,300 | $93,200 |
|
1.48% Nasdaq 
Income Statement
